---
schema_version: "secwatch.filing_event.v1"
accession: "0001842952-25-000003"
form_type: "8-K"
ticker: "CNTX"
cik: "0001842952"
company_name: "Context Therapeutics Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:49:27.478413+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Context Therapeutics appoints Andy Pasternak as Chairman; Richard Berman resigns from Board

## Summary
- Richard Berman resigned from Board effective Jan 12, 2025; not due to any disagreement with the Company.
- Andy Pasternak appointed Chairman effective Jan 13, 2025; term through 2027 annual meeting.
- Pasternak also appointed to Audit and Compensation Committees; Dr. Karen L. Smith named Compensation Committee Chair.
- Pasternak granted options to purchase 20,685 shares, vesting by June 13, 2025 or 2025 annual meeting; receives $55K annual cash retainer.
- Pasternak brings 25+ years pharma experience, including role in $28B Horizon-Amgen acquisition and Bain Healthcare leadership.

## SEC filing metadata
- accession: 0001842952-25-000003
- form_type: 8-K
- ticker: CNTX
- cik: 0001842952
- company_name: Context Therapeutics Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842952/000184295225000003/0001842952-25-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842952/000184295225000003/cntx-20250110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001842952-25-000003
- JSON: https://secwatch.observer/filing/0001842952-25-000003.json
- Plain text: https://secwatch.observer/filing/0001842952-25-000003.txt

## Key facts
- Executive change
  Richard Berman resigned as Director at Context Therapeutics Inc..
  - Action: resigned
  - Role: Director
  source text: On January 10, 2025, Richard Berman gave notice of his resignation from the Board of Directors (the “Board”) of Context Therapeutics Inc. (the "Company"), effective as of January 12, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1842952/000184295225000003/0001842952-25-000003-index.htm
- Executive change
  Andy Pasternak was appointed as Chairperson of the Board at Context Therapeutics Inc..
  - Action: appointed
  - Role: Chairperson of the Board
  source text: the Board appointed Andy Pasternak as a member and Chairperson of the Board, with an initial term expiring at the Company’s 2027 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1842952/000184295225000003/0001842952-25-000003-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.